Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Corporate Governance
2019.08.28
独立董事关于第四届董事会第二十四次会议相关事项的独立意见
2019.06.22
公司章程（2019年6月）
2019.06.22
关于修订《公司章程》的公告
2019.04.29
独立董事关于第四届董事会第二十一次会议相关事项的独立意见
2019.04.29
独立董事2018年度述职报告
2019.03.01
独立董事关于第四届董事会第二十次会议相关事项的独立意见
2018.12.12
第三期员工持股计划管理办法
2018.12.12
独立董事关于第四届董事会第十九次会议相关事项的独立意见
2018.10.30
独立董事关于第四届董事会第十八次会议相关事项的独立意见
2018.09.26
独立董事关于第四届董事会第十七次会议相关事项的独立意见
第一页
上一页
6
7
8
9
10
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
